These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Administration of amantadine for the prevention of Hong Kong influenza. Nafta I; TTurcanu AG; Braun I; Companetz W; Simionescu A; Birţ E; Florea V Bull World Health Organ; 1970; 42(3):423-7. PubMed ID: 5310209 [TBL] [Abstract][Full Text] [Related]
44. A change in the effectiveness of amantadine for the treatment of influenza over the 2003-2004, 2004-2005, and 2005-2006 influenza seasons in Japan. Kawai N; Ikematsu H; Iwaki N; Kawamura K; Kawashima T; Kashiwagi S J Infect Chemother; 2007 Oct; 13(5):314-9. PubMed ID: 17982720 [TBL] [Abstract][Full Text] [Related]
45. The effects of peroral or local aerosol administration of 1-aminoadamantane hydrochloride (amantadine hydrochloride) on influenza infections of the ferret. Fenton RJ; Bessell C; Spilling CR; Potter CW J Antimicrob Chemother; 1977 Sep; 3(5):463-72. PubMed ID: 903327 [No Abstract] [Full Text] [Related]
46. Favorable outcome after treatment with amantadine and ribavirin in a pregnancy complicated by influenza pneumonia. A case report. Kirshon B; Faro S; Zurawin RK; Samo TC; Carpenter RJ J Reprod Med; 1988 Apr; 33(4):399-401. PubMed ID: 3367344 [TBL] [Abstract][Full Text] [Related]
47. A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection. Marra F; Marra CA; Stiver HG Can Respir J; 2003 Oct; 10(7):381-8. PubMed ID: 14571290 [TBL] [Abstract][Full Text] [Related]
48. Ribavirin treatment of experimental respiratory syncytial viral infection. A controlled double-blind study in young adults. Hall CB; Walsh EE; Hruska JF; Betts RF; Hall WJ JAMA; 1983 May; 249(19):2666-70. PubMed ID: 6341640 [TBL] [Abstract][Full Text] [Related]
49. [Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial]. Geppe NA; Kondiurina EG; Galustian AN; Pak TE; Bal'tserovich NB; Zhiglinskaia OV; Kamaev AV; Lazareva SG; Laléko SL; Mel'nikova IM; Perminova OA; Sabitov AU Antibiot Khimioter; 2014; 59(5-6):6-14. PubMed ID: 25552038 [TBL] [Abstract][Full Text] [Related]
50. Amantadine and influenza A. Dolin R Am Fam Physician; 1979 Jan; 19(1):127-30. PubMed ID: 760422 [TBL] [Abstract][Full Text] [Related]
51. Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use. Houck P; Hemphill M; LaCroix S; Hirsh D; Cox N Arch Intern Med; 1995 Mar; 155(5):533-7. PubMed ID: 7864709 [TBL] [Abstract][Full Text] [Related]
52. Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84. Gilbert BE; Wilson SZ; Knight V; Couch RB; Quarles JM; Dure L; Hayes N; Willis G Antimicrob Agents Chemother; 1985 Mar; 27(3):309-13. PubMed ID: 3888102 [TBL] [Abstract][Full Text] [Related]
53. Successful treatment of juvenile chronic arthritis with a specific antiviral agent. Pritchard MH; Munro J Br J Rheumatol; 1989 Dec; 28(6):521-4. PubMed ID: 2590807 [TBL] [Abstract][Full Text] [Related]
56. Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trial. Oker-Blom N; Hovi T; Leinikki P; Palosuo T; Pettersson R; Suni J Br Med J; 1970 Sep; 3(5724):676-8. PubMed ID: 4919024 [TBL] [Abstract][Full Text] [Related]
57. Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected cases. Bueno de Mesquita PJ; Nguyen-Van-Tam J; Killingley B; Enstone J; Lambkin-Williams R; Gilbert AS; Mann A; Forni J; Yan J; Pantelic J; Grantham ML; Milton DK Influenza Other Respir Viruses; 2021 Jan; 15(1):154-163. PubMed ID: 32705798 [TBL] [Abstract][Full Text] [Related]
58. Sensitivity of influenza A virus to amantadine. Jackson GG J Infect Dis; 1977 Aug; 136(2):301-2. PubMed ID: 894081 [No Abstract] [Full Text] [Related]
59. Small-particle aerosols of antiviral compounds in treatment of type A influenza pneumonia in mice. Walker JS; Stephen EL; Spertzel RO J Infect Dis; 1976 Jun; 133 Suppl():A140-4. PubMed ID: 932501 [TBL] [Abstract][Full Text] [Related]
60. Emergence of amantadine-resistant influenza A viruses: epidemiological study. Suzuki H; Saito R; Masuda H; Oshitani H; Sato M; Sato I J Infect Chemother; 2003 Sep; 9(3):195-200. PubMed ID: 14513385 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]